1. Home
  2. CTSO vs PED Comparison

CTSO vs PED Comparison

Compare CTSO & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.70

Market Cap

45.9M

Sector

Health Care

ML Signal

HOLD

Logo Pedevco Corp.

PED

Pedevco Corp.

HOLD

Current Price

$0.55

Market Cap

52.2M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
PED
Founded
1997
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
45.9M
52.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CTSO
PED
Price
$0.70
$0.55
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.38
$1.50
AVG Volume (30 Days)
107.5K
132.1K
Earning Date
03-11-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
156.43
EPS
N/A
0.11
Revenue
$36,979,520.00
$33,244,999.00
Revenue This Year
$7.95
N/A
Revenue Next Year
$8.80
$305.89
P/E Ratio
N/A
$5.20
Revenue Growth
23.89
N/A
52 Week Low
$0.60
$0.43
52 Week High
$1.61
$1.00

Technical Indicators

Market Signals
Indicator
CTSO
PED
Relative Strength Index (RSI) 50.97 50.04
Support Level $0.67 $0.53
Resistance Level $0.74 $0.59
Average True Range (ATR) 0.04 0.03
MACD 0.01 -0.00
Stochastic Oscillator 66.77 44.03

Price Performance

Historical Comparison
CTSO
PED

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

Share on Social Networks: